Investigational Site Number : 7920010

Ankara 06560

0 studies enrolling now · 2 studies all time

What they study most

Dermatitis Atopic, Type 2 Diabetes Mellitus

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids — Completed
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early